BRAF and metastatic malignant neoplasm in the lymph nodes: This finding is of interest, since Ahn et al. found that the patients who were BRAF-positive in all of their nodules had significantly higher rates of extrathyroidal invasion, lymph node metastases, and postoperative radioactive iodine therapy, when compared to the group with mixed mutation status.